Investing Ideas
/
Italian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Italian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Philogen

Market Cap: €834.0m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases.

PHIL

€20.70

13.4%